Gene expression patterns in ovarian carcinomas.
Journal: 2004/April - Molecular Biology of the Cell
ISSN: 1059-1524
Abstract:
We used DNA microarrays to characterize the global gene expression patterns in surface epithelial cancers of the ovary. We identified groups of genes that distinguished the clear cell subtype from other ovarian carcinomas, grade I and II from grade III serous papillary carcinomas, and ovarian from breast carcinomas. Six clear cell carcinomas were distinguished from 36 other ovarian carcinomas (predominantly serous papillary) based on their gene expression patterns. The differences may yield insights into the worse prognosis and therapeutic resistance associated with clear cell carcinomas. A comparison of the gene expression patterns in the ovarian cancers to published data of gene expression in breast cancers revealed a large number of differentially expressed genes. We identified a group of 62 genes that correctly classified all 125 breast and ovarian cancer specimens. Among the best discriminators more highly expressed in the ovarian carcinomas were PAX8 (paired box gene 8), mesothelin, and ephrin-B1 (EFNB1). Although estrogen receptor was expressed in both the ovarian and breast cancers, genes that are coregulated with the estrogen receptor in breast cancers, including GATA-3, LIV-1, and X-box binding protein 1, did not show a similar pattern of coexpression in the ovarian cancers.
Relations:
Content
Citations
(96)
References
(65)
Diseases
(5)
Chemicals
(14)
Genes
(1)
Organisms
(1)
Anatomy
(1)
Affiliates
(2)
Similar articles
Articles by the same authors
Discussion board
Mol Biol Cell 14(11): 4376-4386

Gene Expression Patterns in Ovarian Carcinomas

+17 authors
Stanford University School of Medicine, Stanford, California, 94305-5151
Norwegian Radium Hospital, 0310 Oslo, Norway
University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6055
Corresponding author. E-mail address: ude.drofnats@ydnarb.
P.O.B. is an Investigator of the Howard Hughes Medical Institute.
Received 2003 May 6; Revised 2003 Jul 16; Accepted 2003 Jul 23.

Abstract

We used DNA microarrays to characterize the global gene expression patterns in surface epithelial cancers of the ovary. We identified groups of genes that distinguished the clear cell subtype from other ovarian carcinomas, grade I and II from grade III serous papillary carcinomas, and ovarian from breast carcinomas. Six clear cell carcinomas were distinguished from 36 other ovarian carcinomas (predominantly serous papillary) based on their gene expression patterns. The differences may yield insights into the worse prognosis and therapeutic resistance associated with clear cell carcinomas. A comparison of the gene expression patterns in the ovarian cancers to published data of gene expression in breast cancers revealed a large number of differentially expressed genes. We identified a group of 62 genes that correctly classified all 125 breast and ovarian cancer specimens. Among the best discriminators more highly expressed in the ovarian carcinomas were PAX8 (paired box gene 8), mesothelin, and ephrin-B1 (EFNB1). Although estrogen receptor was expressed in both the ovarian and breast cancers, genes that are coregulated with the estrogen receptor in breast cancers, including GATA-3, LIV-1, and X-box binding protein 1, did not show a similar pattern of coexpression in the ovarian cancers.

Abstract

Acknowledgments

This work was supported by National Institutes of Health Grants R33 CA 89830 (B.I.S.), U01 CA 85129 (P.O.B. and D.B.), and T32 CA09302 (Cancer Biology Training Grant, M.E.S.), California Cancer Research Program Grant 99–00561V-10091 (B.I.S.), the Howard Hughes Medical Institute, and the Margaret Fagin and Beatrice Quackenbush Research Funds for Ovarian Cancer.

Acknowledgments
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.